Cangene Corp.

From Wikipedia, the free encyclopedia

Cangene Corporation

Cangene has built two decades of success producing life-saving antibody products, such as WinRho® SDF. Cangene is a leader in the fight against infectious diseases such as smallpox, hepatitis B and anthrax.

Cangene’s business focuses are hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. Cangene has state-of-the-art R&D and manufacturing operations in Canada and the United States.

Cangene is headquartered in Winnipeg, Manitoba, Canada. It is 80% owned by Canadian pharmaceutical giant Apotex, and has many collaborative agreements with them.